The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hydroxycarbamide-Global Market Insights and Sales Trends 2025
Synopsis
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
The global Hydroxycarbamide market size is expected to reach US$ 342.7 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hydroxycarbamide in various end use industries. The expanding demands from the Sickle Cell Disease, Cancer and Others,, are propelling Hydroxycarbamide market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Global Hydroxycarbamide key players include Qilu Pharmaceutical, Beijing Jialin Pharma, Taj Pharma, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share nearly 60%, followed by Europe, and North America, both have a share about 40 percent.
In terms of product, Capsule is the largest segment, with a share over 60%. And in terms of application, the largest application is Sickle Cell Disease, followed by Cancer, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hydroxycarbamide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hydroxycarbamide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hydroxycarbamide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hydroxycarbamide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hydroxycarbamide covered in this report include Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech and Par Pharma, etc.
The global Hydroxycarbamide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
Global Hydroxycarbamide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hydroxycarbamide market, Segment by Type:
Capsule
Tablet
Global Hydroxycarbamide market, by Application
Sickle Cell Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hydroxycarbamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hydroxycarbamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
The global Hydroxycarbamide market size is expected to reach US$ 342.7 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hydroxycarbamide in various end use industries. The expanding demands from the Sickle Cell Disease, Cancer and Others,, are propelling Hydroxycarbamide market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
Global Hydroxycarbamide key players include Qilu Pharmaceutical, Beijing Jialin Pharma, Taj Pharma, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share nearly 60%, followed by Europe, and North America, both have a share about 40 percent.
In terms of product, Capsule is the largest segment, with a share over 60%. And in terms of application, the largest application is Sickle Cell Disease, followed by Cancer, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hydroxycarbamide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hydroxycarbamide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hydroxycarbamide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hydroxycarbamide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hydroxycarbamide covered in this report include Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech and Par Pharma, etc.
The global Hydroxycarbamide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
Global Hydroxycarbamide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hydroxycarbamide market, Segment by Type:
Capsule
Tablet
Global Hydroxycarbamide market, by Application
Sickle Cell Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hydroxycarbamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hydroxycarbamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hydroxycarbamide Market Overview
1.1 Hydroxycarbamide Product Overview
1.2 Hydroxycarbamide Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Global Hydroxycarbamide Market Size by Type
1.3.1 Global Hydroxycarbamide Market Size Overview by Type (2018-2029)
1.3.2 Global Hydroxycarbamide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hydroxycarbamide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hydroxycarbamide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hydroxycarbamide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hydroxycarbamide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hydroxycarbamide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hydroxycarbamide Sales Breakdown by Type (2018-2023)
2 Global Hydroxycarbamide Market Competition by Company
2.1 Global Top Players by Hydroxycarbamide Sales (2018-2023)
2.2 Global Top Players by Hydroxycarbamide Revenue (2018-2023)
2.3 Global Top Players by Hydroxycarbamide Price (2018-2023)
2.4 Global Top Manufacturers Hydroxycarbamide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hydroxycarbamide Market Competitive Situation and Trends
2.5.1 Hydroxycarbamide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hydroxycarbamide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hydroxycarbamide as of 2022)
2.7 Date of Key Manufacturers Enter into Hydroxycarbamide Market
2.8 Key Manufacturers Hydroxycarbamide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hydroxycarbamide Status and Outlook by Region
3.1 Global Hydroxycarbamide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hydroxycarbamide Historic Market Size by Region
3.2.1 Global Hydroxycarbamide Sales in Volume by Region (2018-2023)
3.2.2 Global Hydroxycarbamide Sales in Value by Region (2018-2023)
3.2.3 Global Hydroxycarbamide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hydroxycarbamide Forecasted Market Size by Region
3.3.1 Global Hydroxycarbamide Sales in Volume by Region (2024-2029)
3.3.2 Global Hydroxycarbamide Sales in Value by Region (2024-2029)
3.3.3 Global Hydroxycarbamide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hydroxycarbamide by Application
4.1 Hydroxycarbamide Market Segment by Application
4.1.1 Sickle Cell Disease
4.1.2 Cancer
4.1.3 Others
4.2 Global Hydroxycarbamide Market Size by Application
4.2.1 Global Hydroxycarbamide Market Size Overview by Application (2018-2029)
4.2.2 Global Hydroxycarbamide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hydroxycarbamide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hydroxycarbamide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hydroxycarbamide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hydroxycarbamide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hydroxycarbamide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hydroxycarbamide Sales Breakdown by Application (2018-2023)
5 North America Hydroxycarbamide by Country
5.1 North America Hydroxycarbamide Historic Market Size by Country
5.1.1 North America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hydroxycarbamide Sales in Volume by Country (2018-2023)
5.1.3 North America Hydroxycarbamide Sales in Value by Country (2018-2023)
5.2 North America Hydroxycarbamide Forecasted Market Size by Country
5.2.1 North America Hydroxycarbamide Sales in Volume by Country (2024-2029)
5.2.2 North America Hydroxycarbamide Sales in Value by Country (2024-2029)
6 Europe Hydroxycarbamide by Country
6.1 Europe Hydroxycarbamide Historic Market Size by Country
6.1.1 Europe Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hydroxycarbamide Sales in Volume by Country (2018-2023)
6.1.3 Europe Hydroxycarbamide Sales in Value by Country (2018-2023)
6.2 Europe Hydroxycarbamide Forecasted Market Size by Country
6.2.1 Europe Hydroxycarbamide Sales in Volume by Country (2024-2029)
6.2.2 Europe Hydroxycarbamide Sales in Value by Country (2024-2029)
7 Asia-Pacific Hydroxycarbamide by Region
7.1 Asia-Pacific Hydroxycarbamide Historic Market Size by Region
7.1.1 Asia-Pacific Hydroxycarbamide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hydroxycarbamide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hydroxycarbamide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hydroxycarbamide Forecasted Market Size by Region
7.2.1 Asia-Pacific Hydroxycarbamide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hydroxycarbamide Sales in Value by Region (2024-2029)
8 Latin America Hydroxycarbamide by Country
8.1 Latin America Hydroxycarbamide Historic Market Size by Country
8.1.1 Latin America Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hydroxycarbamide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hydroxycarbamide Sales in Value by Country (2018-2023)
8.2 Latin America Hydroxycarbamide Forecasted Market Size by Country
8.2.1 Latin America Hydroxycarbamide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hydroxycarbamide Sales in Value by Country (2024-2029)
9 Middle East and Africa Hydroxycarbamide by Country
9.1 Middle East and Africa Hydroxycarbamide Historic Market Size by Country
9.1.1 Middle East and Africa Hydroxycarbamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hydroxycarbamide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hydroxycarbamide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hydroxycarbamide Forecasted Market Size by Country
9.2.1 Middle East and Africa Hydroxycarbamide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hydroxycarbamide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information
10.1.2 Bristol Myers Squibb Introduction and Business Overview
10.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol Myers Squibb Hydroxycarbamide Products Offered
10.1.5 Bristol Myers Squibb Recent Development
10.2 Taj Pharma
10.2.1 Taj Pharma Company Information
10.2.2 Taj Pharma Introduction and Business Overview
10.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Taj Pharma Hydroxycarbamide Products Offered
10.2.5 Taj Pharma Recent Development
10.3 Beijing Jialin Pharma
10.3.1 Beijing Jialin Pharma Company Information
10.3.2 Beijing Jialin Pharma Introduction and Business Overview
10.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Beijing Jialin Pharma Hydroxycarbamide Products Offered
10.3.5 Beijing Jialin Pharma Recent Development
10.4 Qilu Pharmaceutical
10.4.1 Qilu Pharmaceutical Company Information
10.4.2 Qilu Pharmaceutical Introduction and Business Overview
10.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Qilu Pharmaceutical Hydroxycarbamide Products Offered
10.4.5 Qilu Pharmaceutical Recent Development
10.5 Teva Pharma
10.5.1 Teva Pharma Company Information
10.5.2 Teva Pharma Introduction and Business Overview
10.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharma Hydroxycarbamide Products Offered
10.5.5 Teva Pharma Recent Development
10.6 Cipla
10.6.1 Cipla Company Information
10.6.2 Cipla Introduction and Business Overview
10.6.3 Cipla Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cipla Hydroxycarbamide Products Offered
10.6.5 Cipla Recent Development
10.7 Zydus Cadila
10.7.1 Zydus Cadila Company Information
10.7.2 Zydus Cadila Introduction and Business Overview
10.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zydus Cadila Hydroxycarbamide Products Offered
10.7.5 Zydus Cadila Recent Development
10.8 United Biotech
10.8.1 United Biotech Company Information
10.8.2 United Biotech Introduction and Business Overview
10.8.3 United Biotech Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 United Biotech Hydroxycarbamide Products Offered
10.8.5 United Biotech Recent Development
10.9 Par Pharma
10.9.1 Par Pharma Company Information
10.9.2 Par Pharma Introduction and Business Overview
10.9.3 Par Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Par Pharma Hydroxycarbamide Products Offered
10.9.5 Par Pharma Recent Development
10.10 Khandelwal Laboratories
10.10.1 Khandelwal Laboratories Company Information
10.10.2 Khandelwal Laboratories Introduction and Business Overview
10.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Khandelwal Laboratories Hydroxycarbamide Products Offered
10.10.5 Khandelwal Laboratories Recent Development
10.11 Alkem (Cytomed)
10.11.1 Alkem (Cytomed) Company Information
10.11.2 Alkem (Cytomed) Introduction and Business Overview
10.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Alkem (Cytomed) Hydroxycarbamide Products Offered
10.11.5 Alkem (Cytomed) Recent Development
10.12 Samarth Pharma
10.12.1 Samarth Pharma Company Information
10.12.2 Samarth Pharma Introduction and Business Overview
10.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Samarth Pharma Hydroxycarbamide Products Offered
10.12.5 Samarth Pharma Recent Development
10.13 VHB Life Sciences
10.13.1 VHB Life Sciences Company Information
10.13.2 VHB Life Sciences Introduction and Business Overview
10.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue and Gross Margin (2018-2023)
10.13.4 VHB Life Sciences Hydroxycarbamide Products Offered
10.13.5 VHB Life Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hydroxycarbamide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hydroxycarbamide Industrial Chain Analysis
11.4 Hydroxycarbamide Market Dynamics
11.4.1 Hydroxycarbamide Industry Trends
11.4.2 Hydroxycarbamide Market Drivers
11.4.3 Hydroxycarbamide Market Challenges
11.4.4 Hydroxycarbamide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hydroxycarbamide Distributors
12.3 Hydroxycarbamide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
